Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Clinical trial NCT06998095 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06998095
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Severe Asthma Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)

Start date: 2026-11-28
Primary completion: 2029-10-31
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.